Post PCI Angina: Inevitable or Avoidable?

Predictors of post PCI angina 


Among the complications of ischemic cardiomyopathy stenting, those called chronic, with significant functional and mental compromise, might affect patient quality of life. This can be observed in different scenarios, such as instent restenosis and post PCI angina. This kind of complications is associated with anxiety and depression at long term. 

Angina post angioplastia coronaria

According to data from the ISCHEMIA trial, patients with moderate to severe ischemia, initially randomized to an invasive strategy, improved their health status vs. a conservative approach (even more in patients with baseline angina). Also, according to prior registries and studies, post PCI angina can affect from 20 to 40% of patients in the short and mid-term. 

The TARGET-FFR was designed to assess the efficacy of FFR guided PCI optimization vs. the conventional angiography guided PCI. This study incorporated patients with chronic o acute coronary syndrome, stable, randomized 1:1, with symptom follow up according to the Seattle Angina Questionnaire (SAQ-7) and health status monitoring according to the European quality of life-5 dimension-5 level (EQ-5D-5L). Post-PCI angina was defined by follow-up SAQ-angina frequency score <100 (SAQ =100 meaning angina free).

Mean followup was 3 years after PCI; clinical primary end point was target vessel failure (composite end point of cardiovascular death, target vessel MI, target vessel revascularization). 

Read also: BASILICA: a Complex Strategy, Yet Safe.

230 patients were included, mean age 60, 87.8% men, 38.3% with post PCI angina according to SAQ score. 5.7% of these angina patients did not have prior angina (iatrogenic effect). 

Angina patients presented, at baseline, higher ACS incidence and prior PCI vs. angina free-patients, and the presence of atrial fibrillation and smoking was also more frequent among angina patients. 

Coronary angiograms showed no difference in stenosis severity between the groups. Surprisingly, angina free patients had more severe lesions upon physiological analysis and presented more apparent improvement of post PCI indices (hyperemic and non-hyperemic). Post PCI assessment showed no differences in these variables either. 

Read also: Low Gradient Aortic Stenosis: Is Invasive Assessment Viable?

Looking at symptoms, SAQ score was significantly lower, both at baseline and followup, in angina patients. Though moderate, FFR had a positive correlation with SAQ score, as did CFR (weaker correlation). FFR delta after PCI also showed a weak correlation. Single and multivariable analysis determined that small FFR changes after procedure predicted post PI angina. 

Primary end point incidence at followup was 1.7%, with no differences between the angina and angina free groups ((0.7% vs 3.4; P=0.16).

Conclusions

Post PCI residual angina was seen in 38.3% of patients undergoing PCI. Also, these patients presented more symptoms at baseline (according to SAQ) and more often had a history of revascularization and smoking. Baseline FFR and FFR changes were the most important predictors of freedom from angina after PCI. 

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the Editorial Board of SOLACI.org.

Original Title: Angina After Percutaneous Coronary Intervention: Patient and Procedural Predictors.

Reference: Collison D, Copt S, Mizukami T, Collet C, McLaren R, Didagelos M, Aetesam-Ur-Rahman M, McCartney P, Ford TJ, Lindsay M, Shaukat A, Rocchiccioli P, Brogan R, Watkins S, McEntegart M, Good R, Robertson K, O’Boyle P, Davie A, Khan A, Hood S, Eteiba H, Berry C, Oldroyd KG. Angina After Percutaneous Coronary Intervention: Patient and Procedural Predictors. Circ Cardiovasc Interv. 2023 Apr;16(4):e012511. doi: 10.1161/CIRCINTERVENTIONS.122.012511. Epub 2023 Mar 28. PMID: 36974680; PMCID: PMC10101135.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

After a successful atrial fibrillation (AF) ablation, the need to maintain long-term anticoagulation (AC) remains uncertain, especially considering the very low residual embolic risk...

AHA 2025 | VESALIUS-CV: Evolocumab in High-Cardiovascular-Risk Patients Without Prior MI or Stroke

LDL cholesterol is a well-established factor for cardiovascular disease. Therapy with PCSK9 inhibitors, including evolocumab, has been shown to reduce the risk of cardiovascular...

AHA 2025 | TUXEDO-2: Post-PCI Antiplatelet Management in Diabetic Patients with Multivessel Disease — Ticagrelor or Prasugrel?

Choosing the optimal P2Y12 inhibitor for diabetic patients with multivessel coronary artery disease undergoing percutaneous coronary intervention (PCI) remains a major clinical challenge. These...

AHA 2025 | DECAF: Coffee Consumption vs. Abstinence in Patients with Atrial Fibrillation: Recurrence or Myth?

The link between coffee consumption and arrhythmia has been met with contradicting recommendations. It is widely believed that caffeine could trigger atrial fibrillation (AF)...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Atrial Fibrillation After Percutaneous Patent Foramen Ovale Closure: Cohort Study with Continuous Implantable Cardiac Monitoring

Atrial fibrillation (AF) is a recognized complication following percutaneous closure of a patent foramen ovale (PFO), with reported incidences of up to 30% during...

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

AHA 2025 | OPTIMA-AF: 1 Month vs. 12 Months of Dual Therapy (DOAC + P2Y12) After PCI in Atrial Fibrillation

Concomitant atrial fibrillation (AF) and coronary artery disease is a common occurrence in clinical practice. In these patients, current guidelines recommend 1 month of...